ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2026

Is next generation sequencing for the diagnosis of rare diseases worth its cost? A user-based approach to valuation.

Karen V MacDonald et al.PubMed ↗Publisher ↗

No numbers read from the abstract.